PhysicianUniversity of North Carolina Chapel HillChapel Hill, North Carolina, United States
LB 02.1 - Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial.
Tuesday, June 27, 202310:45 – 11:00 ET